Immunology Market Report 2024 (Global Edition)

Global Immunology Market Report 2024 Market Size Split by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody, Others), by Disease Indication (Rheumatoid Ar...

Immunology Market Report Description

We have various report editions of Immunology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Immunology Market Insights Video

Competitive Landscape of the Immunology Market

The competitive landscape of the Immunology market is characterized by rapid innovation and significant investment from major pharmaceutical and biotechnology companies. Key players include Pfizer, Johnson & Johnson, Merck & Co., and AbbVie, which led in developing of advanced immunotherapies and vaccines. The market also features numerous emerging biotech firms focused on novel treatments and personalized medicine. Competitive strategies include strategic alliances, mergers and acquisitions, and extensive R&D investments. Companies are increasingly focusing on breakthrough technologies such as CAR-T cell therapies and immune checkpoint inhibitors to gain a competitive edge. Regulatory approvals and patent protections play crucial roles in shaping competitive dynamics.

May 2024: Human Immunology Biosciences, a privately held clinical-stage biotechnology company that specializes in customized treatments for people with severe immune-mediated diseases (IMOS), and Biogen Inc., an American multinational biotechnology company, announced that they had both signed a definitive agreement. The agreement states that Biogen would pay US$ 1.15 billion to acquire Hi-Bio initially, with the possibility of further milestone payments of up to US$ 650 million. (Source: https://investors.biogen.com/news-releases/news-release-details/biogen-completes-acquisition-human-immunology-biosciences) April 2023: Prometheus Biosciences, Inc., a biopharmaceutical startup, and Merck, branded as MSD, a worldwide scientific and technology business, announced that they had inked a definitive agreement. This deal states that Prometheus will be acquired by Merck for US$200.00 per share in cash through a subsidiary. (Source:https://www.merck.com/news/merck-strengthens-immunology-pipeline-with-acquisition-of-prometheus-biosciences-inc/) October 2022: The US FDA approved the combination of tremelimumab (Imjudo) and durvalumab (Imfinzi) for patients with unresectable hepatocellular carcinoma, the most common kind of liver cancer. (Source: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-tremelimumab-combination-durvalumab-unresectable-hepatocellular-carcinoma)

Top Companies Market Share in Immunology Industry: (In no particular order of Rank)

• Teva Pharmaceutical Industries Ltd
• UCB S.A.
• Regeneron Pharmaceuticals Inc.
• AbbVie Inc
• Johnson & Johnson
• Biogen Inc
• GlaxoSmithKline
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the ImmunologyMarket

Which Region Dominates the Immunology Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue by advanced healthcare infrastructure, high research investment, and strong pharmaceutical innovation. The U.S. leads with significant market share due to its extensive R&D capabilities, robust healthcare systems, and a large patient population contributing to high demand for immunological therapies.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the immunology market due to increasing healthcare investments, expanding patient populations, and rising awareness of immunological diseases. The region's rapidly growing pharmaceutical industry and advanced research facilities further boost market expansion.

The current report Scope analyzes Immunology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Immunology Market

According to Cognitive Market Research, the global Immunologymarket size was estimated at USD 99548.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 39819.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Immunology market with a market size of USD 31417.41 million in 2024 and is projected to grow at a CAGR of 10.6% during the forecast period. The nation's with advanced research and innovation.
• The Canada Immunology Market had a market share of USD 4778.31 million in 2024 and is projected to grow at a CAGR of 11.6% during the forecast period. Canada's strict due to strong research investment.
• The Mexico Immunology market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 3623.55 million in 2024.

Europe Immunology Market

According to Cognitive Market Research, the global Immunologymarket size was estimated at USD 99548.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 29864.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.

• The United Kingdom Immunology Market had a market share of USD 5017.23 million in 2024 and is projected to grow at a CAGR of 11.9% during the forecast period. In the UK, Immunologysales witness an upswing due to strong investments.
• The French immunology market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 2747.53 million in 2024.
• According to Cognitive Market Research, the German Immunology Market size was valued at USD 5913.16 million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period. In Germany, Immunology surged due to strong research investments.
• The Italy Immunology Market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 2568.34 million in 2024.
• The Russian immunology Market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 4628.99 million in 2024.
• The Spain Immunologymarket is projected to witness growth at a CAGR of 10.2% during the forecast period with a market size of USD 2448.89 million in 2024
• The Luxembourg Immunology Market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 925.80 million in 2024.
• The Portugal Immunology market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 627.15 million in 2024.
• The Greece Immunology Market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 358.37 million in 2024.
• Rest of Europe's Immunologymarket is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 4628.99 million in 2024.

Asia Pacific Immunology Market

According to Cognitive Market Research, the global Immunology market size was estimated at USD 99548.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 22896.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.

• According to Cognitive Market Research, the China Immunology Market size was valued at USD 10303.24 million in 2024 and is projected to grow at a CAGR of 14.1% during the forecast period. Immunology surged in China due to strong R&D investment.
• The Japan Immunology market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 3159.66 million in 2024.
• The India Immunology Market had a market share of USD 3159.66 million in 2024 and is projected to grow at a CAGR of 16.4% during the forecast period. India is supportive of advanced healthcare infrastructure.
• The South Korean Immunology Market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 2289.61 million in 2024.
• The Australian Immunology Market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 1190.60 million in 2024.
• The South East Asia Immunology Market is projected to witness growth at a CAGR of 15.6% during the forecast period, with a market size of USD 1579.83 million in 2024.
• The Rest of Asia Pacific Immunology market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 1625.62 million in 2024.

South America Immunology Market

According to Cognitive Market Research, the global Immunology market size was estimated at USD 99548.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 4977.41 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.0% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Immunology Market size was valued at USD 2130.33 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period. Immunology flourished in Brazil due to robust healthcare infrastructure driving growth.
• Argentina's Immunologymarket had a market share of USD 836.20 million in 2024 and is projected to grow at a CAGR of 12.9% during the forecast period. Argentina's Strong healthcare infrastructure and increasing prevalence of autoimmune diseases boost growth.
• Colombia Immunologymarket is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 442.99 million in 2024.
• Peru Immunologymarket is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 408.15 million in 2024.
• Chile Immunologymarket is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 358.37 million in 2024.
• The Rest of Latin America's immunology market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 801.36 million in 2024.

Middle East and Africa Immunology Market

According to Cognitive Market Research, the global Immunology market size was estimated at USD 99548.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 1990.96 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031..

• The GCC Countries Immunology Market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 852.13 million in 2024. Immunologysales flourish through innovation and investments.
• The Egypt Immunology Market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 209.05 million in 2024.
• The South Africa Immunology Market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 314.57 million in 2024. Immunologysales flourish in South Africa due to innovation, research, and healthcare advancements.
• The Turkey Immunology Market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 171.22 million in 2024.
• The Nigeria Immunology Market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 209.05 million in 2024.
• The Rest of the MEA Immunology market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 234.93 million in 2024.

Immunology Market Analysis

ImmunologyMarket Drug Class Segment Analysis

According to Cognitive Market Research, Monoclonal Antibody (mAb) stands out as the dominant category due to its high specificity and effectiveness in targeting diseases, particularly autoimmune disorders and cancers. They are engineered to recognize and bind to specific antigens, enhancing the immune system's ability to combat pathogens or malignant cells. mAbs are widely used in therapies for conditions like rheumatoid arthritis, psoriasis, and various cancers, driving their demand. Advances in biotechnology have improved their production and reduced costs, further solidifying their market position. Their versatility, effectiveness, and expanding therapeutic applications contribute to their dominance in the immunology sector.

Immunosuppressants emerge as the fastest-growing category in the Immunology market. Immunosuppressants, due to their critical role in treating autoimmune diseases and preventing organ transplant rejection. As the prevalence of autoimmune disorders like rheumatoid arthritis and multiple sclerosis rises, demand for these drugs surges. Advances in biologics and targeted therapies further enhance their effectiveness, driving market expansion. Additionally, the increasing number of organ transplants worldwide necessitates the use of immunosuppressants to prevent rejection, bolstering their market presence. With ongoing research and development, newer and more potent immunosuppressants are continually entering the market, solidifying their dominance in the immunology sector.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Immunology Industry. Request a Free Sample PDF!

Immunology Market Disease Indication Segment Analysis

According to Cognitive Market Research, the dominant category is Rheumatoid arthritis due to its high prevalence and the significant demand for effective treatments. R.A. is a chronic autoimmune disease that affects millions worldwide, leading to joint inflammation and damage. The complexity and chronic nature of R.A. drive continuous innovation and investment in immunological therapies, including biologics and targeted synthetic drugs. These treatments represent a substantial portion of the immunology market, with leading pharmaceutical companies focusing on R.A. drug development. The persistent need for advanced therapies to manage R.A. symptoms and slow disease progression ensures its dominance in the immunology sector.

The fastest-growing category in the immunology market is Psoriatic Arthritis due to increased awareness, early diagnosis, and advancements in targeted biologic therapies. Biologics, especially TNF inhibitors and IL-17/23 inhibitors, are highly effective in managing PsA symptoms, driving the market growth. The rise in PsA cases, alongside the overlap with psoriasis, boosts demand for innovative treatments. Moreover, as more pharmaceutical companies invest in research and development, the market sees a surge in novel therapeutics, expanding options for personalized care. This competitive landscape and unmet patient needs position PsA as a key driver in the evolving immunology market.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Immunology Distribution Channel Segment Analysis

ImmunologyMarket Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominant category is Hospital pharmacies due to their critical role in the distribution and administration of immunology treatments, including biologics and advanced therapies. These pharmacies are often integrated with specialized departments, allowing for precise management of complex immunological conditions. They ensure the availability of high-cost, specialized medications, often administered in inpatient or outpatient settings. Additionally, hospital pharmacies are key in clinical trials and patient education, reinforcing their central position in the immunology market. Their ability to handle the logistics and patient care required for immunology therapies makes them a dominant force in this sector.

The fastest-growing category in the immunology market is Retail Pharmacies; by leveraging their extensive networks and accessibility allows them to reach a broad patient base efficiently. They offer convenience through widespread locations, extended hours, and integrated digital services like online prescriptions and home delivery. Retail pharmacies also benefit from strong relationships with pharmaceutical manufacturers, enabling them to offer a wide range of immunology products. Additionally, they provide immunization services and education, increasing patient engagement and trust. Their ability to rapidly adapt to market trends and meet consumer demand makes them key players in the fast-growing immunology market.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion